Literature DB >> 20496206

Sample sizes required to detect two-way and three-way interactions involving slope differences in mixed-effects linear models.

Moonseong Heo1, Andrew C Leon.   

Abstract

Based on maximum likelihood estimates obtained from mixed-effects linear models, closed-form power functions are derived to detect two-way and three-way interactions that involve longitudinal course of outcome over time in clinical trials. Sample size estimates are shown to decrease with increasing within-subject correlations. It is further shown that when clinical trial designs are balanced in group sizes, the sample size required to detect an effect size for a three-way interaction is exactly fourfold that required to detect the same effect size of a two-way interaction. Furthermore, this fourfold relationship virtually holds for unbalanced allocations of subjects if one factor is balanced in the three-way interaction model. Simulations are presented that verify the sample size estimates for two-way and three-way interactions.

Mesh:

Year:  2010        PMID: 20496206     DOI: 10.1080/10543401003618819

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  20 in total

1.  Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designs.

Authors:  Francisco J Diaz; Michel J Berg; Ron Krebill; Timothy Welty; Barry E Gidal; Rita Alloway; Michael Privitera
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

2.  Sample size requirements for detecting treatment effect heterogeneity in cluster randomized trials.

Authors:  Siyun Yang; Fan Li; Monique A Starks; Adrian F Hernandez; Robert J Mentz; Kingshuk R Choudhury
Journal:  Stat Med       Date:  2020-08-21       Impact factor: 2.373

3.  Interaction Between Alcohol Consumption Patterns, Antiretroviral Therapy Type, and Liver Fibrosis in Persons Living with HIV.

Authors:  Usama Bilal; Bryan Lau; Mariana Lazo; Mary E McCaul; Heidi E Hutton; Mark S Sulkowski; Richard D Moore; Geetanjali Chander
Journal:  AIDS Patient Care STDS       Date:  2016-05       Impact factor: 5.078

4.  Depressive symptoms as a moderator of college student response to computerized alcohol intervention.

Authors:  Mary Beth Miller; Nicole Hall; Angelo M DiBello; Chan Jeong Park; Lindsey Freeman; Ellen Meier; Eleanor L S Leavens; Thad R Leffingwell
Journal:  J Subst Abuse Treat       Date:  2020-05-22

5.  Do Immediate Gains Predict Long-Term Symptom Change? Findings from a Randomized Trial of a Single-Session Intervention for Youth Anxiety and Depression.

Authors:  Jessica L Schleider; Madelaine R Abel; John R Weisz
Journal:  Child Psychiatry Hum Dev       Date:  2019-10

6.  Combat experiences, pre-deployment training, and outcome of exposure therapy for post-traumatic stress disorder in Operation Enduring Freedom/Operation Iraqi Freedom veterans.

Authors:  Matthew Price; Daniel F Gros; Martha Strachan; Kenneth J Ruggiero; Ron Acierno
Journal:  Clin Psychol Psychother       Date:  2012-01-18

7.  Age differences in treatment response to a collaborative care intervention for anxiety disorders.

Authors:  Julie Loebach Wetherell; Andrew J Petkus; Steven R Thorp; Murray B Stein; Denise A Chavira; Laura Campbell-Sills; Michelle G Craske; Cathy Sherbourne; Alexander Bystritsky; Greer Sullivan; Peter Roy-Byrne
Journal:  Br J Psychiatry       Date:  2013-04-11       Impact factor: 9.319

Review 8.  The importance of gene-environment interactions in human obesity.

Authors:  Hudson Reddon; Jean-Louis Guéant; David Meyre
Journal:  Clin Sci (Lond)       Date:  2016-09-01       Impact factor: 6.124

9.  Romantic involvement: A protective factor for psychological health in racially-diverse young sexual minorities.

Authors:  Sarah W Whitton; Christina Dyar; Michael E Newcomb; Brian Mustanski
Journal:  J Abnorm Psychol       Date:  2018-02-01

10.  Sample size requirements to detect a two- or three-way interaction in longitudinal cluster randomized clinical trials with second-level randomization.

Authors:  Moonseong Heo; Xiaonan Xue; Mimi Y Kim
Journal:  Clin Trials       Date:  2014-05-16       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.